FDA In Brief: FDA continues to encourage ongoing education about the benefits and risks associated with PrEP, including additional steps to help reduce the risk of getting HIV

Because patients and doctors understand the risks of using Truvada for PrEP, and educational materials are available from CDC, FDA eliminated the REMS for Truvada and its generics.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news